Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt issuances
Ratios

Cresco Labs (CRLBF) Other Gross PP&E Adjustments (2020 - 2026)

Cresco Labs filings provide 7 years of Other Gross PP&E Adjustments readings, the most recent being -$17.2 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 84.36% to -$17.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$17.2 million, a 84.36% increase, with the full-year FY2025 number at $496.3 million, up 21.84% from a year prior.
  • Other Gross PP&E Adjustments hit -$17.2 million in Q1 2026 for Cresco Labs, down from $495.9 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $495.9 million in Q4 2025 to a low of -$147.9 million in Q4 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$110.1 million (2025), compared with a mean of -$4.6 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 1053.3% in 2022 and later skyrocketed 360.22% in 2023.
  • Cresco Labs' Other Gross PP&E Adjustments stood at -$147.9 million in 2022, then skyrocketed by 360.22% to $384.9 million in 2023, then increased by 5.83% to $407.4 million in 2024, then rose by 21.74% to $495.9 million in 2025, then crashed by 103.47% to -$17.2 million in 2026.
  • The last three reported values for Other Gross PP&E Adjustments were -$17.2 million (Q1 2026), $495.9 million (Q4 2025), and -$15.4 million (Q3 2025) per Business Quant data.